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Abstract
Purpose: To investigate the mechanisms underpinning modifications in glucose homeostasis and insulin sensitivity 24 h
after a bout of resistance exercise (RE) with or without protein ingestion.
Methods: Twenty-four healthy males were assigned to a control (CON; n=8), exercise (EX; n=8) or exercise plus protein
condition (EX+PRO; n=8). Muscle biopsy and blood samples were obtained at rest for all groups and immediately post-RE
(75% 1RM, 8610 repetitions of leg-press and extension exercise) for EX and EX+PRO only. At 24 h post-RE (or post-resting
biopsy for CON), a further muscle biopsy was obtained. Participants then consumed an oral glucose load (OGTT) containing
2 g of [U-
13C] glucose during an infusion of 6, 6-[
2H2] glucose. Blood samples were obtained every 10 min for 2 h to
determine glucose kinetics. EX+PRO ingested an additional 25 g of intact whey protein with the OGTT. A final biopsy sample
was obtained at the end of the OGTT.
Results: Fasted plasma glucose and insulin were similar for all groups and were not different immediately post- and 24 h
post-RE. Following RE, muscle glycogen was 2668 and 1966% lower in EX and EX+PRO, respectively. During OGTT, plasma
glucose AUC was lower for EX and EX+PRO (75.162.7 and 75.362.8 mmol?L
21:120 min, respectively) compared with CON
(90.664.1 mmol?L
21:120 min). Plasma insulin response was 1362 and 2164% lower for EX and CON, respectively,
compared with EX+PRO. Glucose disappearance from the circulation was ,12% greater in EX and EX+PRO compared with
CON. Basal 24 h post-RE and insulin-stimulated PAS-AS160/TBC1D4 phosphorylation was greater for EX and EX+PRO.
Conclusions: Prior RE improves glycemic control and insulin sensitivity through an increase in the rate at which glucose is
disposed from the circulation. However, co-ingesting protein during a high-glucose load does not augment this response at
24 h post-exercise in healthy, insulin-sensitive individuals.
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Introduction
Metabolic complications, such as insulin resistance and Type II
diabetes, represent a major individual and public health burden
[1] and are associated with the presence of obesity and physical
inactivity [2,3,4]. Suppressed pancreatic b cell insulin production
[5] and impaired glucose uptake in skeletal muscle [6,7], are major
contributors to hyperglycemia, which eventually leads to Type II
diabetes. Insulin stimulates the uptake of glucose from the
circulation into many body tissues, of which, skeletal muscle
accounts for ,75–80% [8,9]. Insulin-stimulated glucose uptake in
skeletal muscle occurs via insulin-dependent signalling that
promotes glucose transporter (GLUT4) translocation to the cell
membrane. Even though pharmacologic approaches are available
to manage Type II diabetes, The American Diabetes Association
states that ‘‘physical activity and dietary modifications are central
to the management and prevention of Type II diabetes’’ and when
medications are used to control Type II diabetes, ‘‘they should
augment lifestyle improvements, not replace them’’ [10].
Skeletal muscle contraction can effectively enhance glucose
uptake independent of insulin. Importantly, these properties are
preserved in individuals with Type II diabetes [11,12]. A number
of studies have demonstrated that aerobic exercise improves
glycemic control and insulin sensitivity [13,14,15,16]. More
recently, evidence has emerged to suggest that a single bout of
resistance exercise (RE) improves whole-body insulin sensitivity
[17,18,19] and glycemic control [20], with the beneficial effects of
RE on glycemic control and insulin sensitivity noted primarily
between 12–24 h post-RE. However, not all studies demonstrate a
beneficial effect of RE on glucose metabolism [21,22].
Insulin regulates GLUT4 translocation from an intracellular
location to the cell surface via a well-described pathway involving
protein kinase B (Akt) and the recently discovered GTPase, Akt
substrate of 160 kDa (AS160/TBC1D4) [23]. Although enhanced
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that bypass proximal insulin-signalling intermediates, such as Akt
[24,25,26], AS160/TBC1D4 appears to act as a point of
convergence for insulin- and contraction-stimulated glucose
transport in skeletal muscle [23,27,28]. Recently, basal and
insulin-stimulated AS160/TBC1D4 phosphorylation was shown
to increase in the acute post-exercise phase in humans [23,29] and
remain elevated for up to 27 h post-exercise in rodents [30].
However, whether AS160/TBC1D4 remains elevated in the 24 h
post exercise period has not been investigated in humans.
In addition to RE, dietary modifications that acutely raise
endogenous insulin secretion, represent a clinically relevant
strategy to improve blood glucose homeostasis in Type II diabetes.
A number of recent studies suggest that co-ingesting protein and/
or amino acids with carbohydrate induces a greater insulin release
than the ingestion of either macronutrient alone [31,32,33,34].
Indeed, the rise in plasma insulin with the ingestion of frequent,
small boluses of carbohydrate plus protein, blunts the prevailing
glucose response in Type II diabetics [35,36], primarily due to an
increase in the rate of glucose disposal from the circulation [35].
Thus, in persons with Type II diabetes, co-ingesting protein with
each main meal may be an effective strategy to acutely lower
postprandial glucose excursions [32,37]. The combined effect of
protein ingestion and RE has largely been considered in the
context of muscle hypertrophy [38,39]. However, the hypothesis
that post-RE protein ingestion, provided in a physiologically dose,
acutely enhances glucose uptake has not been investigated in
humans.
Therefore, we hypothesized that the beneficial effects of RE on
post-prandial blood glucose homeostasis at 24 h post-RE would be
explained by contraction-dependant alteration in rates of glucose
disposal. Furthermore, we expected that the increase in glucose
disposal with prior exercise would occur in parallel to increased
activation of the Akt/AS160/TBC1D4 signaling cascade. Finally,
we postulated that co-ingestion of protein during an oral glucose
load would elevate the insulin response and augment the glucose-
lowering effect observed following RE.
Methods
Participants
Twenty-four untrained, recreationally active, healthy males
were recruited through advertisements to participate in the study.
Individuals who were engaged in regular structured resistance or
endurance training, defined as $2 training sessions per week of
60 mins or more, were ineligible to participate. All testing visits
were completed within a 3-week period. The purpose and
methodology of the study were clearly explained to the
participants. All participants gave their informed consent prior
to taking part in the study and were deemed healthy based on their
response to a general health questionnaire. The experimental
protocol was approved by the NHS Birmingham East, North &
Solihull Research Ethics Committee (Rec No: 09/H1206/102).
Study design
In a randomized, parallel designed study, participants were
assigned to either a non-exercise control (CON; n=8), exercise
only (EX; n=8) or exercise plus protein (EX+PRO; n=8)
condition. A parallel study design, in contrast to a crossover
design, was chosen as ethical requirements meant that limitations
were imposed on the number of muscle biopsy samples we could
obtain per participant. Participant characteristics are presented in
Table 1. Following a preliminary assessment of maximal lower-
limb strength, participants reported to the laboratory after an
overnight fast, on two consecutive mornings. On the first morning,
a resting muscle biopsy sample was obtained, thereafter EX and
EX+PRO performed an intense lower-limb resistance workout. A
second biopsy was obtained immediately post-exercise for EX and
EX+PRO only. Twenty-four hours later another muscle biopsy
was obtained, after which, participants completed an oral glucose
tolerance test (OGTT). Participants assigned to EX+PRO co-
ingested protein with the OGTT to determine whether the
addition of protein augmented the impact of resistance exercise on
glucose metabolism. During OGTT, dual isotopic glucose tracers
were utilized and frequent blood samples obtained over 2 h to
determine glucose kinetics and insulin sensitivity. A final muscle
biopsy was obtained at the end of the 2 h OGTT to examine the
phosphorylation of contraction- and insulin-mediated signalling
intermediates.
Preliminary testing
Body Mass. A digital scale was used to determine body mass
to the nearest 0.1 kg. Participant weight and height were recorded
in exercise clothing without shoes on. This was repeated prior to
each of the two testing visits to ensure body mass remained stable
throughout testing.
Maximal Strength. Bilateral 1 Repetition Maximum (1RM)
was determined for leg press and leg extension exercises (Cybex
VR/3). After warming up at a self selected resistance, the load was
set at a level designed to allow the subject to perform at least two,
but less than ten repetitions before failure. This estimation
protocol of 1RM was designed to minimise the number of
attempts necessary to determine 1RM [40]. After each successful
lift the load was increased by 2.5–5 kg until failure to complete two
repetitions. Between each successive attempt a 2 min rest period
was allowed. A repetition was considered valid if the participant
used proper form and was able to complete the entire lift in a
controlled manner without assistance.
Diet and Physical Activity Control. Participant diet was
standardized for the entire 48 h testing period. During preliminary
testing participants completed a 3-day food diary, representative of
their average week (two week days and one weekend day). A
questionnaire of food preferences was also completed by
participants. Using an on-line diet planner (Weight Loss
Resources) the total energy and macronutrient content of each
of the 3-days was estimated. Food parcels were provided to each
participant with a total energy and macronutrient intake
equivalent to their average habitual intake. Thus, participant
Table 1. Characteristics of participants in each group.
Parameter CON (n=8) EX(n=8) EX+PRO (n=8)
Age (y) 22632 0 632 2 66
Weight (kg) 77.066.3 79.7614.5 75.6613.1
BMI (kg?m
22) 2462.3 25.163.9 23.564.8
LP 1RM (kg) 200644 212650 206660
LP 1RM (kg?BM
21) 5.760.8 5.961.8 6.061.3
LE 1RM (kg) 111622 121621 115629
LE 1RM (kg?BM
21) 3.561.2 3.760.7 3.460.6
Exercise volume (kg) ¯ 18,31462154 18,27762406
CON: resting control group, EX: exercise only group, EX+PRO: exercise plus
protein group. BMI: body mass index, 1RM: one-repetition maximum, LP: leg
press, LE: leg extension. Exercise volume is defined as number of
repetitions6number of sets6weight lifted. Values are presented as means 6 SD.
doi:10.1371/journal.pone.0020613.t001
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instructed to consume only the food provided for them over the
two-day testing period (i.e. 24 h prior to Day 1 and during Day 1).
There was no difference in total energy intake or macronutrient
composition of the food parcels for CON, EX and EX+PRO
(Table 2).
Physical activity control. Participants were instructed to
maintain normal habitual activities of daily living but to refrain
from any strenuous activity for 48 h prior to reporting to the
laboratory on Day 1. After completion of testing on Day 1,
participants were also instructed to refrain from strenuous activity
prior to returning the following morning on Day 2.
Treatment trials
Day 1 - Exercise/Control Trial. Participants reported to
the Human Performance Laboratory between 0600 and 0700 h
after an overnight fast, 7–14 days after preliminary strength tests.
After resting in a supine position for 30 min a cannula was inserted
into an antecubital forearm vein and a resting blood sample was
obtained for analysis of background isotopic enrichment.
Thereafter, the lateral portion of one thigh was prepared under
local anaesthetic (1% Lidocaine) and a 5-mm Bergstrom biopsy
needle was used to extract a muscle biopsy sample from the vastus
lateralis muscle. The biopsied leg was bandaged and EX and
EX+PRO were instructed to complete a bout of intense lower-
limb resistance exercise, whereas CON were permitted to
consume the standardized breakfast and leave the laboratory.
For EX and EX+PRO a second biopsy sample was obtained post-
exercise (661 min) 1 cm distal from the resting biopsy. For EX
and EX+PRO both biopsy incisions were made at rest to allow the
post-exercise biopsy sample to be obtained as quickly as possible.
The order of biopsied leg was counterbalanced between groups.
Biopsy samples were blotted and freed of any visible fat and
connective tissue, frozen in liquid nitrogen (within ,60 s of being
taken from the muscle) and stored at 280uC until further analysis.
The resistance exercise bout consisted of a standardized warm-
up on a leg-press machine (12650% 1RM+10660% 1RM+8
670% 1RM+2675% 1RM) followed by 8 sets of 10 bilateral
repetitions at 75% 1RM. Participants then completed 8 sets of 10
bilateral repetitions on a leg-extension machine at 75% 1RM. The
exercise protocol was chosen to match that used by Koopman and
colleagues [17], in order to achieve an exercise effect on glycemic
control. In the event that a participant failed to complete all 10
repetitions in a set, the weight was decreased by 2.5–5 kg for the
following set. Failure was defined as the point at which the exercise
could not be completed or technique failed. Participants were
instructed on proper lifting cadence using a metronome set to 50
beats min
21, which corresponded to 1 s concentric muscle action,
0 s pause and a 1 s eccentric muscle action. Strong verbal
encouragement was given throughout exercise. Between-set rest
intervals of 2 min were given and participants completed the
exercise bout in 4563 min. Participants were permitted to
consume water ad libitum throughout Day 1.
Day 2 - Infusion Trial. Participants returned to the
laboratory the following morning between 0600 and 0700 h
after an overnight fast. A schematic diagram of the study protocol
is presented in Figure 1. A cannula was inserted into the
antecubital vein of one arm for the infusion of a stable isotopic
tracer. A second cannula was inserted into a hand vein of the
opposite arm and a resting venous blood sample obtained. At a
time-point corresponding to ,23 h post-exercise for EX and
EX+PRO a primed infusion of 6, 6-[
2H2] glucose (Cambridge
Isotope Laboratories, MA, USA) was initiated (prime:
13.5 mmol.kg
21; infusion: 0.35 mmol.kg
21.min
21) and continued
for ,180 min. For CON, the infusion was initiated at a time-point
corresponding to ,23 h after the resting biopsy on Day 1.
Approximately 60 min into the infusion (,24 h post-exercise or
resting biopsy) a muscle biopsy sample was obtained from the
vastus lateralis of the opposite leg to that sampled the previous day.
Immediately after the muscle biopsy was obtained CON and EX
consumed an oral glucose load (oral glucose tolerance test;
OGTT) described below. EX+PRO consumed the same glucose
load plus additional protein. The time at which the beverage was
completely consumed was considered t=0, thereafter participants
rested in the supine position and venous blood samples were
obtained every 10 min until t=120. A final muscle biopsy sample
was obtained at t=120 from a separate incision (,26 h post-
exercise or resting biopsy). Water intake was restricted during Day
2 to ensure participants consumed only the treatment beverage.
Treatment beverages
Sixty minutes into the infusion on Day 2, participants ingested
73 g of glucose (80.3 g dextrose monohydrate when corrected for
water content) plus an additional 2 g of [U-
13C] glucose (99%,
Cambridge Isotope Laboratories, MA, USA) to determine the
contribution of exogenous glucose production to the total rate of
appearance of glucose. Thus, participants ingested a total of 75 g
of glucose. Participants assigned to EX+PRO ingested an
additional 25 g of whey protein with the 75 g glucose load.
Glucose was provided in the form of dextrose monohydrate
obtained from Roquette
TM (Lestrem, France) and intact whey
protein (Volactive ultrawhey 90) was a generous gift from Volac
TM
(Royston, UK). The amino acid content of the protein was (in
percent content, wt:wt): Ala, 5; Arg, 2.1; Asp, 11; Cys, 2.2; Gln,
18.1; Gly, 1.4; His, 1.7; Ile, 6.4; Leu, 10.6; Lys, 9.6; Met, 2.2; Phe,
3; Pro, 5.5; Ser, 4.6; Thr, 6.7; Trp, 1.4; Tyr, 2.6; and Val, 5.9.
Both treatments were consumed in water in a total volume of
300 mL. Treatments were not matched for flavour or appearance
due to the parallel study design. Participants were instructed to
consume the treatment beverage within 2 min.
Analyses
Blood analytes. Blood was collected in EDTA-containing
tubes and spun at 3,500 rpm for 15 min at 4uC. Aliquots of
plasma were then frozen and stored at 280uC until later analysis.
Plasma glucose concentration was analyzed using an ILAB
automated analyzer (Instrumentation Laboratory, Cheshire,
UK). Plasma insulin concentration was analyzed using a
commercially available ELISA kit (IBL International, Hamburg,
Germany) following the manufacturer’s instructions. The enrich-
ment of [
13C] and [
2H2] glucose in plasma was determined by gas
chromatography-mass spectrometry (model 5973; Hewlett
Packard, Palo Alto, CA). Derivatization was carried out with
butane boronic acid in pyridine and acetic anhydride. The glucose
Table 2. Participant habitual dietary intake and
macronutrient composition.
CON (n=8) EX (n=8) EX+PRO (n=8)
Daily energy intake (kJ) 9,3536469 9,4876691 10,3456452
Carbohydrate (%) 71.166.6 66.263.9 6967.1
Protein (%) 15.863.0 18.263.3 17.966.5
Fat (%) 13.163.1 15.660.4 13.164.8
Groups as per Table 1. Values are presented as means 6 SEM.
doi:10.1371/journal.pone.0020613.t002
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charge ratios (m/z) 297, 299 and 303 for [
12C]-, [
2H2]- and
[U-
13C] glucose, respectively. Two sets of enriched standards were
measured containing known amounts of [
2H2]- and [U-
13C]
glucose. By establishing the relationship between the enrichment
of the glucose standards, the enrichment in plasma samples was
determined.
Western blots. Muscle biopsy samples (,40 mg) were
powdered on dry ice under liquid nitrogen using a mortar and
pestle. Approximately 25 mg of powdered muscle was
homegenized in lysis buffer (50 mM Tris pH 7.5; 250 mM
Sucrose; 1 mM EDTA; 1 mM EGTA; 1% Triton X-100; 1 mM
NaVO4; 50 mM NaF; 0.50% PIC) using a hand-held
homogenizer (PRO200, UK). Samples were shaken at 4uC for
30 min (12,000 rpm), centrifuged for 5 min at 6,000 g and the
supernatant removed for protein determination. Protein
concentration was determined using the DC protein assay (Bio
Rad, Hertfordshire, UK). Equal aliquots of protein were boiled in
Laemmli sample buffer (250 mM Tris-HCl, pH 6.8; 2% SDS;
10% glycerol; 0.01% bromophenol blue; 5% b-mercaptoethanol)
and separated on SDS polyacrylamide gels (10–12.5%) for 1 h at
58 mA. Following electrophoresis; proteins were transferred to a
Protran nitrocellulose membrane (Whatman, Dassel, Germany)
at 100 V for 1 h. Samples from each of the three experimental
conditions were loaded onto the same gel, such that each gel
contained eleven samples (3 from CON, 4 from EX and 4 from
EX+PRO). Total protein and phosphorylated protein were run
concurrently on back-to-back gels using the same samples. The
membranes were incubated overnight at 4uC with the
appropriate primary antibody. The following morning, the
membrane was rinsed in wash buffer (TBS with 0.1% Tween-
20) three times for 5 min. The membrane was then incubated for
1 h at room temperature within wash buffer containing the
appropriate secondary antibody, either horseradish (HRP)-linked
anti-mouse IgG (New England Biolabs, 7072; 1:1,000) or anti-
rabbit IgG (New England Biolabs, 7074; 1:1,000). The
membrane was then cleared in wash buffer three times for
5 min. Antibody binding was detected using enhanced
chemiluminescence (Millipore, Billerica, MA). Imaging and
band quantification were carried out using a Chemi Genius
Bioimaging Gel Doc System (Syngene, Cambridge, UK).
Insufficient muscle tissue in 6 subjects (2 per group) meant that
western blot analyses were determined for 18 participants (n=6
per group). The primary antibodies used were total Akt (CAT),
Akt
ser473 (Cell signalling 3787), PAS-AS160/TBC1D4 (Cell
Signalling) and total AS160/TBC1D4, a generous gift from
Prof. Grahame Hardie, University of Dundee. Total p70S6K and
phospho p70S6K
Thr389 were from Santa Cruz (11759/7984R)
and total PRAS40 and phospho PRAS40
Thr246 were from Cell
Signalling (2610).
Immunoprecipitations. Endogenous AS160/TBC1D4 and
p70S6K proteins were immuno-precipitated (IP) overnight at 4uC
with 0.8 mg of AS160/TBC1D4 or p70S6K antibodies in a mix of
protein G-agarose beads (Millipore, Glostrup, DK) and lysate
(600 mg). The following day immunocomplexes were washed three
times in homogenization buffer and three times in TNE (10 mM
Tris, pH 7.5, 150 mM NaCl, 10 mM EDTA and 0.1 mM
Na2VO4). The immunocomplexes were re-suspended in 50 mL
of 16Laemmli sample buffer and boiled for 5 min (100uC) upon
which they were subjected to western blotting as previously
described.
Muscle glycogen measurement. Powdered muscle
(,20 mg) was hydrolyzed in 250 ml of 2 M HCl by heating at
95uC for 3 h. The solution was neutralized with 250 ml2 M
NaOH and the resulting free glycosyl units were assayed
spectrophotometrically using a hexokinase-dependant assay kit
(Glucose HK, ABX diagnostics, UK) against glucose standards of
known concentrations [41].
Figure 1. Schematic diagram of the study protocol. (A) Indicates protocol for exercise only and exercise plus protein participants. (B) Indicates
protocol for non-exercised control participants.
doi:10.1371/journal.pone.0020613.g001
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Insulin sensitivity. Plasma glucose and insulin
concentrations during the 120 min OGTT were used to
determine the whole-body insulin sensitivity index (ISI)
according to the following equation of Matsuda [42]:
Matsuda ISI~
10000
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(FPG:FPI):(mean OGTT insulin)
:(mean OGTT glucose)
s ð1Þ
Where FPG is the fasting plasma glucose concentration, FPI is the
fasting insulin concentration and 1000 represents a constant that
allows numbers between 1 and 10 to be obtained.
Post-absorptive insulin sensitivity was also estimated by the
homeostasis model assessment (HOMA-IR) index which is
calculated by dividing the product of FPG and FPI by 22.5 [43].
Glucose kinetics. From the [
2H2] glucose tracer, the total Ra
(Eq. 2) and Rd (Eq. 3) of glucose were calculated with the single-
pool non-steady-state equations of Steele [44] as modified for use
with stable isotopes [45]. Total Ra represents the splanchnic Ra of
glucose from ingested glucose, the liver and potentially some
glycogenolysis and gluconeogenesis from the kidneys.
Ra total~
F - (V:(C2 z C1)=2:(Ep2{Ep1)=t2{t1))=(Ep2zEpl)=2)
ð2Þ
Rd~Ra total{V: (C2zC1=t2{t1) ð3Þ
Where F is the infusion rate; Epl and Ep2 are the [
2H2] glucose
enrichments in plasma at time-points t1 and t2, respectively; C1
and C2 are glucose concentrations at t1 and t2, respectively; and V
is volume of distribution in 160 mL?kg
21.
The [U-
13C] glucose tracer added to each beverage was used to
calculate the Ra of glucose from the gut. The Ra of [
13C] glucose
(Ra gut) into plasma was determined by transposition of the Steele
equation and the known
13C enrichment of the ingested glucose
[46] adapted for use with stable isotopes [47].
F2~
Ra: ½(Ep2zEp1)=2z(C2zC1)=2:(Ep2{Ep1)= t2{t1 ðÞ :V 
ð4Þ
Where F2 is the Ra of [
13C] glucose in the blood; Ra is the
previously determined total Ra of glucose (Eq. 2). Knowing the Ra
of [
13C] glucose in the blood, one can determine the absorption
rate of glucose from the gut from the known enrichment of the
ingested glucose.
Ra gut~F2
 
Eing ð5Þ
Where Ra gut is the Ra of gut-derived glucose and Eing is the
13C
enrichment of the ingested glucose. The rate of endogenous
glucose (EGP) was calculated as the difference between Ra total
and Ra gut.
EGP ~ Ra total - Ra gut ð6Þ
Ra,R d,R a gut and EGP were converted to g.min
21 for graphical
representation (=mmol?kg
21?min
216kg6180.2/10
26).
Statistical Analysis
A between-subject repeated measures design was utilized for the
current study. Exercise variables, blood analytes, plasma enrich-
ment and Western blot data were analyzed using a two-way
ANOVA with repeated measures (treatment6time) to determine
differences between each condition across time. When a significant
main effect or interaction was identified, data were subsequently
analyzed using a Bonferroni post hoc test. Plasma glucose and
insulin concentrations over the 120 min OGTT were calculated as
area under the curve (AUC). Within-group changes over time;
glucose kinetics and blood analyte AUC data were checked for
statistical significance using one-way repeated-measures ANOVA.
All statistical tests were analyzed using statistical package for social
sciences (SPSS) version 18.0 (Illinois, Chicago, U.S). Significance
for all analyses was set at P,0.05. All values are presented as
means 6 standard error of the mean (SEM).
Results
Dietary intake
Dietary analysis indicated that daily energy intake and
macronutrient composition of the diet was similar for CON, EX
and EX+PRO (Table 2). Thus, the contents of the standardized
diet provided prior to and during Day 1 of the study were similar
for all groups.
Exercise variables
Leg-press and leg-extension 1RM values determined during
pre-testing were not different between groups (Table 1). Based on
the measured 1RM, the resistance lifted on the leg-press machine
during Day 1 was 150617 and 156617 kg and for EX and
EX+PRO, respectively (P.0.05). Leg-extension resistance was set
at 85611 and 8469 kg for EX and EX+PRO, respectively
(P.0.05). All participants were able to complete the leg-press
exercise without reducing the weight. Six participants (four from
EX and two from EX+PRO) were unable to complete the leg-
extension exercise at the desired resistance, which was then
lowered by 2.5–5 kg to enable participants to complete ten
repetitions. However, the total exercise volume performed for EX
and EX+PRO was not different (Table 1).
Plasma glucose
Fasting plasma glucose (5.160.4, 5.360.7 and
5.760.2 mmol?L
21 for CON, EX and EX+PRO, respectively)
were in the normal range. Basal plasma glucose concentrations
were similar on Day 2 (24 h post-exercise) for all groups (5.660.3,
4.960.3 and 5.160.6 mmol?L
21 for CON, EX and EX+PRO,
respectively). During the OGTT, plasma glucose concentration
increased in all groups, peaking 30–50 min after feeding (P,0.05;
Figure 2A). Plasma glucose peaked at 9267, 8869 and 8068%
above basal fasted values for CON, EX and EX+PRO,
respectively. Following the peak, plasma glucose concentration
decreased, such that by 120 min post-OGTT plasma glucose
concentration had returned to basal fasted values. Plasma glucose
AUC during OGTT was 1763% lower for EX and EX+PRO
(P=0.02 for both) compared with CON (Figure 2B).
Plasma insulin
Fasting plasma insulin concentrations (7.260.6, 5.960.7 and
7.160.6 mU?ml
21 for CON, EX and EX+PRO, respectively)
were in the normal range. Basal plasma insulin concentrations
were similar on Day 2 for all groups (6.260.7, 6.560.4 and
6.960.5 mU?ml
21 for CON, EX and EX+PRO, respectively).
Plasma insulin concentrations during OGTT increased by 8.6-,
Exercise and Protein for Glucose Homeostasis
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EX+PRO, respectively peaking 30–40 min after feeding
(Figure 3A). Plasma insulin AUC during OGTT was significantly
greater for EX+PRO compared with EX (P=0.04) and CON
(P=0.01). There was no difference in insulin AUC between EX
and CON (Figure 3B).
Figure 2. Plasma glucose concentration (A) and AUC (B) during OGTT 24 h following resistance exercise in untrained volunteers.
Groups as per Table 1. Values are means 6SEM; n=8 per group. *: significantly greater glucose concentration/AUC for CON compared with EX and
EX+PRO (P,0.05).
doi:10.1371/journal.pone.0020613.g002
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1.5560.13, 1.6960.32 and 1.5160.12 for CON, EX and
EX+PRO, respectively. HOMA-(IR) index was not different on Day
2 (1.4660.17, 1.560.12 and 1.6460.17 for CON, EX and EX+PRO,
respectively). Post-prandial insulin sensitivity, calculated using the
Matsuda ISI, was greater for EX and EX+PRO (6.9560.5 and
6.8260.41, respectively) compared with CON (6.2160.72; P,0.05).
There was no difference in Matsuda ISI between EX and EX+PRO.
Figure 3. Plasma insulin concentration (A) and AUC (B) during OGTT 24 h following resistance exercise in untrained volunteers.
Groups as per Table 1. Values are means 6SEM; n=8 per group. *: significantly greater insulin concentration/AUC than CON (P,0.05). {: significantly
greater insulin concentration than EX. (P,0.05).
doi:10.1371/journal.pone.0020613.g003
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Plasma enrichment of infused 6, 6-[2H
2] and ingested [U-
13C]
glucose are presented in Figure 4A. Ra total, Ra gut, EGP and Rd
over time are presented in Figure 4 (B, C, D, respectively).
Average plasma glucose tracer kinetics are presented in Table 3.
In all groups, plasma glucose Ra total increased over time
(P,0.05), peaking 70–90 min after feeding (Figure 4B). There
was no difference in the plasma glucose Ra total between groups.
Glucose Ra gut demonstrated an increasing contribution to Ra
total with time (P,0.05), whereas EGP demonstrated a reduced
contribution to Ra total with time (P,0.05; Figure 4C). The
increase in Ra gut peaked 70–90 min after feeding, whereas the
decline in EGP reached a nadir 90–100 min after feeding.
Glucose Rd increased over time in all groups (P,0.05; Figure 4D).
Glucose Rd increased by 127613, 131615 and 150618% above
basal values for CON, EX and EX+PRO, respectively. Glucose
Rd was significantly lower for CON 40–70 min after feeding
compared with EX and EX+PRO (P,0.05). Average glucose Rd
and whole-body glucose disposal, (Rd expressed as % of Ra total)
was significantly lower for CON compared with EX and
EX+PRO (P,0.01; Table 3). The time taken for Rd to match
the Ra total was greater for CON than EX and EX+PRO
(P,0.05). There was no difference in average glucose tracer
kinetics between EX and EX+PRO.
Muscle glycogen
Basal muscle glycogen concentration was similar for all groups
(Figure 5). Immediately post-exercise, muscle glycogen concentra-
tion was 2668 and 1966% lower for EX and EX+PRO (P,0.05),
with no difference between groups. Muscle glycogen concentration
at 24 h post-exercise had returned to basal values for all groups.
There was no significant change in muscle glycogen concentration
following OGTT (,26 h post-exercise), compared with 24 h post-
exercise. The absolute change in muscle glycogen content (Table 4)
was greater for EX and EX+PRO compared to CON when
measured immediately post-RE-to-24 h post-RE (P,0.01) and
during OGTT from 24 h-to-26 h post-RE (P,0.05).
Protein phosphorylation
Basal PAS-AS160/TBC1D4 phosphorylation (Day 1) was
similar for all groups (Figure 6A). Compared with basal, AS160/
TBC1D4 phosphorylation did not change immediately post-
exercise but was increased at 24 h post-exercise for EX and
EX+PRO only (P,0.05) and was greater compared with CON
(P,0.01). At 26 h post-exercise, following OGTT, AS160/
TBC1D4 phosphorylation increased by 1.4-fold for CON and
1.3-fold for EX and EX+PRO compared with 24 h post-exercise
(P,0.05) and was greater compared with CON (P,0.05). Basal
Akt
ser473 phosphorylation (Day 1) was similar for all groups
Figure 4. Tracer enrichments and glucose kinetics over 120 min OGTT. (A) Enrichment of 6, 6-[
2H2] and [U-
13C] glucose in plasma.
Average for all 3 groups presented, n=24. MPE (%): mole percent excess. (B) Total rate of glucose appearance in plasma (Ra). (C) Contribution of
exogenous glucose appearing from the gut (Ra gut) and endogenous glucose production (EGP) to the Ra Total; solid lines indicate Ra gut, dashed
arrows indicate EGP. (D) Rate of glucose disappearance from plasma (Rd). Means with different subscripts are significantly different from each other.
*: significantly lower Rd for CON compared with EX and EX+PRO. Values are means 6SEM; n=8 per group.
doi:10.1371/journal.pone.0020613.g004
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change immediately post- and 24 h post-exercise in all groups. At
26 h post-exercise, following OGTT, Akt phosphorylation in-
creased by 2.2-, 2.3 and 1.9-fold for CON, EX and EX+PRO,
respectively, compared with 24 h post-exercise (P,0.05). Akt
phosphorylation at 26 h post-exercise was greater for EX and
EX+PRO compared with CON (P,0.05). Basal p70S6K
Thr389
and PRAS40
Thr246 phosphorylation (Day 1) was similar for all
groups (Figure 6C and 6D, respectively). Compared with basal,
p70S6K and PRAS40 phosphorylation was not different imme-
diately-, 24 h- or 26 h-post exercise. There was no between-group
difference in p70S6K or PRAS40 phosphorylation immediately-,
24 h- or 26 h-post exercise. All representative western blot images
are presented in Figure 7.
Discussion
The present study expands on previous investigations [17,20,48]
by providing a physiological mechanism as to how a single bout of
intense, lower-body resistance exercise (RE) improves insulin
sensitivity in healthy, normoglycemic adults. We demonstrate that
prior RE suppresses plasma glucose excursions during an oral
glucose tolerance test (OGTT) by increasing the rate of glucose
disposal from the circulation. The improvement in insulin-
stimulated glucose disposal with prior RE can be attributed in
part, to a greater insulin-stimulated phosphorylation of Akt and
greater basal and insulin-stimulated phosphorylation of AS160/
TBC1D4. However, contrary to our initial hypothesis, co-
ingesting protein during OGTT did not augment the response
Table 3. Plasma glucose kinetics for the 3 groups during OGTT.
CON (n=8) EX (n=8) EX+PRO (n=8)
Ra total (g?min
21) 0.3460.02 0.3660.02 0.3660.03
Ra gut (g?min
21) 0.2460.03 0.2660.03 0.2660.04
Exogenous contribution (Ra gut as % of Ra) 65.766 68.566 65.967
EGP (g?min
21) 0.160.01 0.160.01 0.160.01
Endogenous contribution (EGP as % of Ra) 34.267 31.467 33.967
Rd (g?min
21) 0.3160.02* 0.3560.02 0.3560.02
Glucose disposal (Rd as % of Ra) 89.461.7* 94.160.5 95.960.6
Time for Rd to match Ra (min) 5968* 42654 5 66
Ingested glucose appearance (%) 38.467.1 41.667.6 42.267.8
Data presented for [6, 6-
2H2] glucose rate of appearance (Ra total) and disappearance (Rd)a n dR d expressed as % of Ra. Contribution of exogenous [U-
13C] glucose from
the gut (Ra Gut) and endogenous glucose production (EGP) to Ra total are presented. Groups as per Table 1.
*indicates significantly lower than EX and EX+PRO (P,0.05). Values are presented as means 6 SEM over 120 min OGTT.
doi:10.1371/journal.pone.0020613.t003
Figure 5. Muscle glycogen content. Values obtained at basal, immediately post-exercise (Post 0), 24 h post-exercise (Post 24) and immediately
following OGTT (Post 26). Groups as per Table 1. Values are means 6 SEM; n=6 per group. *: significantly lower compared with basal (P,0.05).
doi:10.1371/journal.pone.0020613.g005
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resistance exercise despite a greater insulin response.
To date, studies investigating the acute effect of RE on insulin
sensitivity and glucose homeostasis have provided conflicting
results [17,18,20,21,22,48]. The discrepancies between prior
studies may be due, in large part, to methodological differences
with the exercise volume or intensity potentially impacting the
response of insulin sensitivity to exercise. Prior studies utilizing a
relatively low-volume whole-body RE protocol [18,21] showed no
effect on plasma glucose in healthy young [18,22] and insulin
resistant populations [18,21]. On the other hand, Koopman et al.
[17] demonstrate that a lower-limb RE protocol with total volume
,3-fold greater than the aforementioned studies [18,21], is
sufficient to improve insulin sensitivity in healthy adults. Recent
results also suggest that both the intensity and volume of RE
impact glucose control in individuals with impaired fasting glucose
[19]. Taken together, these findings suggest that higher exercise
volumes may be necessary to elicit improvements in insulin
sensitivity following RE. Moreover, RE clearly represents an
alternative to endurance-type exercise [13,14,15,16] as an effective
means of improving glycemic control.
The 17% reduction in plasma glucose response we observed
with prior RE is consistent with previous studies [20]. Total
glucose appearance and the contribution from endogenous and
exogenous sources was not different between groups, indicating
that gastric emptying, intestinal uptake and hepatic glucose output
were not altered by prior RE or protein co-ingestion during
OGTT. However, plasma glucose disappearance/disposal from
the circulation did increase with prior RE. Further, we calculated
that the time taken for glucose disappearance to match glucose
appearance was reduced by ,37%. The changes in glycogen
Table 4. Absolute change in muscle glycogen.
CON (n=6) EX (n=6) EX+PRO (n=6)
Basal – Post 0 – 284.96221.9 259.66217.1
Post 0–Post 24 13.965.7 71.1622.4** 54.9615.2**
Post 24–Post 26 5.863.2 27.1611.6* 38.6618.4*
Groups as per Table 1. Change from basal to immediately post-exercise (Basal –
Post 0), immediately post-exercise to 24 h post-exercise (Post 0–Post 24) and
24 h post-exercise to 26 h post-exercise (Post 24–Post 26). No change in
glycogen assumed for CON from Basal – Post 0. Values are presented as means
6 SEM (mmol.kg
21.ww).
*Significantly different from CON during the same time period (P,0.05).
**Significantly different from CON during the same time period and (P,0.01).
doi:10.1371/journal.pone.0020613.t004
Figure 6. Signalling protein phosphorylation of (A) Akt
ser473, (B) PAS-AS160/TBC1D4, (C) p70S6K
Thr389 and (D) PRAS40
Thr246 from
muscle samples taken at 4 different time points. Groups as per Table 1. Values are means 6 SEM; n=6 per group. Means with different letters
are significantly different from each other (P,0.05). *: significantly lower phosphorylation for CON compared with EX and EX+PRO (P,0.05).
doi:10.1371/journal.pone.0020613.g006
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intervention to reverse the compromised insulin-stimulated glucose
disposal that is prevalent in Type II diabetes [49].
A number of studies have found that prior exercise has no effect
on proximal insulin signalling steps, such as Akt phosphorylation
[50,51]. Similarly, we report no effect of RE on basal Akt
phosphorylation at 24 h post-exercise. In contrast, phosphoryla-
tion of the Rab-GTPase-activating protein AS160/TBC1D4, was
greater at 24 h post-exercise. Studies in humans [23,29] have
demonstrated that basal and insulin-stimulated AS160/TBC1D4
phosphorylation is increased several hours post-exercise. Until
now, the sustained effect of prior exercise on AS160/TBC1D4
phosphorylation has been demonstrated only in rodent models
[31]. Here we show for the first time, in humans, that AS160/
TBC1D4 phosphorylation is greater at 24 h post-RE compared
with basal and non-exercise values. Moreover, although the
insulin-stimulated rise in AS160/TBC1D4 phosphorylation was
similar for all groups, the absolute level of AS160/TBC1D4
phosphorylation was greater for EX and EX+PRO compared with
CON following the OGTT. Thus, these data support the notion
that increased exercise-induced glucose disposal is associated with
AS160/TBC1D4 activation. It should be noted however that the
small sample size of our experimental groups might have meant
that subtle differences in the activation of proteins in the insulin
signalling pathway were undetectable.
To our knowledge, this study is the first to examine whether
protein co-ingestion augments the response of RE on glycemic
control 24 h post-exercise. Under resting conditions, it has been
demonstrated that the marked increase in plasma insulin
concentrations that prevails when protein and/or amino acids
are ingested with carbohydrate can effectively increase glucose
disposal [35] and reduce plasma glucose excursions [31,52]. In our
hands, the elevated insulin response with protein co-ingestion did
not augment the RE-induced rise in glucose disposal or lower
plasma glucose excursions in healthy, normoglycemic individuals.
We posit that the lack of a glycemic-lowering effect of additional
protein could be attributed to the insulin response to our feeding
protocol. Our data reveal that the transient rise in plasma insulin
with additional protein was greater between 30–50 min post-
feeding (21 and 13% greater than CON and EX, respectively) but
was no longer evident by 60 min. In contrast, studies that report a
glucose lowering effect with protein co-ingestion have favoured
frequent feeding of small boluses to promote a sustained rise in
plasma insulin, over several hours; much greater than the present
study [31,35,52,53]. Thus, this relatively brief period of hyperin-
sulinemia may have been insufficient to further lower plasma
glucose excursions. However, we chose a single bolus feed to
provide a closer representation of the physiological effects of a
typical meal, albeit, we acknowledge, one containing more glucose
than would usually be consumed by Type II diabetics. The impact
of more frequent protein feeding has not been assessed following
resistance exercise.
Finally, it is worth mentioning that the studies discussed above,
reporting a glucose-lowering effect of protein co-ingestion were
conducted under resting conditions [31,35,52,53]. In contrast, we
report no additive effect of protein co-ingestion, perhaps due to the
fact that the glucoregulatory effects of feeding were assessed
following high-intensity RE in healthy, insulin-sensitive partici-
pants. Thus, it is possible that the RE stimulus, in healthy adults, is
sufficient to promote skeletal muscle glucose uptake to ‘optimal’
levels, beyond which the addition of protein confers no further
benefit. Further, our skeletal muscle signalling data indicate that
Figure 7. Representative protein phosphorylation blots. Proteins phosphorylation was studied in the basal, fasted state (Basal), immediately
post-exercise (Post 0), 24 h post-exercise (Post 24) and 26 h post-exercise following the OGTT (Post 26) and normalized to total protein content.
doi:10.1371/journal.pone.0020613.g007
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not augmented by additional protein and a greater insulin
response. Based on our data, it is unclear whether protein
ingestion would augment the glucose-lowering effect of prior RE
in Type II diabetics, in whom insulin secretion and glucose
transport are impaired.
In conclusion, we have shown that high-intensity resistance
exercise improves insulin sensitivity and increases the rate of
postprandial glucose disposal, which subsequently lowers post-
prandial glucose excursions in healthy, normoglycemic adults.
Whereas these data are positive, we acknowledge that such
exercise volumes may not be feasible for all insulin resistant/type
II diabetic patients. To date, the minimum RE dose required to
counteract symptoms of metabolic disease has not been deter-
mined and certainly warrants further investigation.
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